A Recap On The Pharmaceuticals & Healthcare Outlook For 2016: Asia Pacific
The year 2016 marked a highly dynamic year for the Asia Pacific pharmaceutical market. In particular, the region saw significant discussion over the healthcare aspect of the Trans-Pacific Partnership as the governments involved sought to win the support of their populations and enact changes needed to bring their regulations in line with the requirements of the trade deal. In addition, Asia-based pharmaceutical firms continued their expansion across the region, with Japanese firms in particular taking a notably strong push outwards. This will have significant implications for multinational drugmakers operating in Asia, as it brings additional competition.